David P. Abney
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Northrop Grumman: Demand Intact Despite Softer Sentiment. Morgan Stanley notes that aerospace and defense demand remains steady as the company heads into earnings, even though market sentiment has eased. Northrop Grumman is expanding its supplier network through the ANH Structure and LITEF, and its precision weapons business could help sustain growth. The company’s valuation is below that of competitor Anduril, adding context to the sector’s competitive landscape.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Target (TGT) in focus as sales growth and dividend outlook discussed. Recent articles note that Target's sales growth has improved its outlook and that its 3.35% dividend is being compared to peers. Analysts also consider how the latest Federal Reserve policy could influence consumer spending at retailers like Target. A new nationwide launch of Javvy Coffee's peppermint mocha at Target stores adds a fresh product offering. The stock is currently near a long‑standing support level.
Transaction History
| FCX | ▲ Buy | Grant | 2,800 | $0 | 6/1/2026 | View on chart |
| NOC | ▲ Buy | Grant | 349 | $193K | 5/20/2026 | View on chart |
| TGT | ▲ Buy | Grant | 1,676 | $0 | 3/11/2026 | View on chart |
| FCX | ▲ Buy | Grant | 4,900 | $0 | 6/1/2025 | View on chart |
| NOC | ▲ Buy | Grant | 385 | $182K | 5/21/2025 | View on chart |
| TGT | ▲ Buy | Grant | 1,841 | $0 | 3/12/2025 | View on chart |
| NOC | ▲ Buy | Grant | 377 | $183K | 7/31/2024 | View on chart |
| FCX | ▲ Buy | Grant | 3,500 | $0 | 6/1/2024 | View on chart |
| TGT | ▲ Buy | Grant | 1,148 | $0 | 3/13/2024 | View on chart |
| FCX | ▲ Buy | Grant | 5,000 | $0 | 6/1/2023 | View on chart |
| NOC | ▲ Buy | Grant | 392 | $175K | 5/17/2023 | View on chart |
| TGT | ▲ Buy | Grant | 1,166 | $0 | 3/8/2023 | View on chart |
| FCX | ▲ Buy | Grant | 4,500 | $0 | 6/1/2022 | View on chart |
| NOC | ▲ Buy | Grant | 385 | $175K | 5/18/2022 | View on chart |
| TGT | ▲ Buy | Grant | 878 | $0 | 3/9/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
FCX Grasberg on schedule amid cash flow valuation questions
Recent news highlights that Freeport-McMoRan's Grasberg operation is back on schedule, supporting its production outlook. However, market commentary questions whether the stock is priced for perfection on cash flow, with copper prices acting as a key test. The company's valuation of 33.9 times trailing earnings reflects high market expectations for cash flow delivery.
FCX Grasberg on schedule amid cash flow valuation questions. Recent news highlights that Freeport-McMoRan's Grasberg operation is back on schedule, supporting its production outlook. However, market commentary questions whether the stock is priced for perfection on cash flow, with copper prices acting as a key test. The company's valuation of 33.9 times trailing earnings reflects high market expectations for cash flow delivery.